Pediatr Infect Dis J
Administration, IntravenousAntiviral AgentsGanciclovir
Dr. Mark Thomas Vander Lugt, MD
NPI1861562985PAC ID8921257189
- Part D claims, 2024
- 13
- Publications
- 20
- Hospital affiliations
- 1
- Industry payments
- $1,042
- Medical group
- 1
- Practice address
- 1500 E Medical Center Dr, Ann Arbor, MI 48109
- Practice phone
- Call (734) 936-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
University Hospital
School-Based Health Center · Ann Arbor, Michigan
Find Dr. Vander Lugt's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark Thomas Vander Lugt is a pediatric hematology and oncology physician in Ann Arbor, Michigan
Dr. Vander Lugt practices at University Hospital in Ann Arbor, Michigan.
Dr. Vander Lugt's NPI, 1861562985, was assigned on November 8, 2006. Dr. Vander Lugt graduated from Medical College of Wisconsin in 2006. Dr. Vander Lugt holds Michigan license 4301094130.
NPI and contact details
- NPI
- 1861562985NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8921257189
- NPI enumeration date
- November 8, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (734) 936-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 46
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mark Thomas Vander Lugt practices at University Hospital in Ann Arbor, Michigan
Dr. Vander Lugt's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.
- University Hospital1500 E Medical Center Dr, Ann Arbor, MI 48109Phone(734) 936-4000
Source: Dmand AI Affiliation Data
Dr. Mark Thomas Vander Lugt is affiliated with 2 sites of care and 1 medical group
Dr. Vander Lugt's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Vander Lugt is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dr. Vander Lugt's employer is on file too: a school & student health.
University HospitalPrimary
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mark Thomas Vander Lugt's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vander Lugt practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Vander Lugt practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark Thomas Vander Lugt is one of 86 pediatric hematologys and oncology physicians in Michigan
Pediatric hematology-oncology is Dr. Vander Lugt's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dmand AI has Dr. Vander Lugt's licenses on file in 2 states: Michigan and Pennsylvania.
Specialties and state licenses
- Pediatric hematology and oncology, MichiganPrimary
- Pennsylvania license
Pediatric hematologys and oncology physicians near Dr. Vander Lugt
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
86pediatric hematologys and oncology physicians in Michigan31pediatric hematologys and oncology physicians in Ann Arbor
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark Thomas Vander Lugt's patients have a median age of 15
Across all payers, Dmand AI patient panel data puts Dr. Vander Lugt's median patient age at 15, with 42% women.
Dr. Vander Lugt's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 15
Patient panel by sex, all payers
- Women42%
- Men57%
Source: Dmand AI Patient Panel Data
Dr. Mark Thomas Vander Lugt wrote 13 Medicare Part D claims in 2024
In 2024, Dr. Vander Lugt wrote 13 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $276 in total drug cost. In 2021, CMS named 12 claims across 1 drug.
Part D claims, 202413
Drugs named by CMS1
Total drug cost$276
Dr. Vander Lugt's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 122022: 138%
Drugs named by CMS: 1 in 2022, 1 in 2021.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Mark Thomas Vander Lugt takes part in Medicare
Dr. Vander Lugt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find pediatric hematologys and oncology physicians like Dr. Vander Lugt by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark Thomas Vander Lugt has 20 publications on record
Dmand AI links 20 papers to Dr. Vander Lugt, published from 2011 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Severe Combined Immunodeficiency. Dr. Vander Lugt has published most often in Blood. Dr. Vander Lugt's most frequent co-authors are Jeffrey John Bednarski, MD, Morton J. Cowan, MD and Christopher C. Dvorak, MD.
Papers20
Years published2011 to 2024
Dr. Vander Lugt's papers by year, 2011 to 2024
Topics Dr. Vander Lugt writes about most
- Hematopoietic Stem Cell Transplantation
- Graft vs Host Disease
- Severe Combined Immunodeficiency
- Adenosine Deaminase
- Alemtuzumab
- Antigens, Neoplasm
- Antiviral Agents
- Biomarkers, Tumor
Dr. Vander Lugt's most frequent co-authors
- Jeffrey John Bednarski, MD4 shared papers
- Morton J. Cowan, MD4 shared papers
- Christopher C. Dvorak, MD4 shared papers
Recent publications by Dr. Vander Lugt
AlemtuzumabCell ProliferationCord Blood Stem Cell Transplantation
See who Dr. Vander Lugt researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Vander Lugt works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark Thomas Vander Lugt received $1,042 in industry payments from 2019 to 2024
CMS Open Payments shows 6 general payments to Dr. Vander Lugt from 2 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. National Marrow Donor Program paid the most, $772.
General payments to Dr. Vander Lugt by program year, 2019 to 2024
Companies that paid Dr. Vander Lugt the most, 2019 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mark Thomas Vander Lugt graduated from Medical College of Wisconsin
Dr. Vander Lugt graduated from Medical College of Wisconsin in 2006.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mark Thomas Vander Lugt's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark Thomas Vander Lugt
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark Thomas Vander Lugt's NPI number?
Dr. Mark Thomas Vander Lugt's NPI number is 1861562985. It was assigned on November 8, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark Thomas Vander Lugt?
Dr. Mark Thomas Vander Lugt is a pediatric hematology and oncology physician in Ann Arbor, Michigan. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Mark Thomas Vander Lugt practice?
Dr. Vander Lugt practices at 1500 E Medical Center Dr, Ann Arbor, MI 48109. Dr. Vander Lugt's primary practice is University Hospital in Ann Arbor, Michigan.
What is Dr. Mark Thomas Vander Lugt's office phone number?
The practice phone on file for Dr. Vander Lugt is (734) 936-4000.
What is Dr. Mark Thomas Vander Lugt's medical license number?
Dr. Vander Lugt holds Michigan license 4301094130, one of the licenses on file in 2 states.
Which states has Dr. Mark Thomas Vander Lugt been licensed in?
Dmand AI has state licenses on file for Dr. Vander Lugt in Michigan and Pennsylvania.
Which hospitals is Dr. Mark Thomas Vander Lugt affiliated with?
Dr. Vander Lugt is affiliated with University Hospital.
What medical group is Dr. Mark Thomas Vander Lugt part of?
Dr. Vander Lugt is linked to University of Michigan Health.
Does Dr. Mark Thomas Vander Lugt accept Medicare?
Yes. CMS lists Dr. Vander Lugt as accepting Medicare assignment.
Where did Dr. Mark Thomas Vander Lugt go to medical school?
Dr. Vander Lugt graduated from Medical College of Wisconsin in 2006.
Show 5 more questionsShow fewer questions
What drugs does Dr. Mark Thomas Vander Lugt prescribe most?
In 2022 Medicare Part D data, Dr. Vander Lugt's most prescribed drugs by claims were Sulfamethoxazole-Trimethoprim.
Has Dr. Mark Thomas Vander Lugt received payments from drug or device companies?
CMS Open Payments shows $1,042 in general payments to Dr. Vander Lugt from 2 companies from 2019 to 2024. The largest total came from National Marrow Donor Program.
How long has Dr. Mark Thomas Vander Lugt been practicing?
Dr. Vander Lugt graduated from medical school in 2006, 20 years ago.
Does Dr. Mark Thomas Vander Lugt do research?
Dmand AI links 20 publications to Dr. Vander Lugt, published from 2011 to 2024.
Who does Dr. Mark Thomas Vander Lugt publish with?
Dr. Vander Lugt's most frequent co-authors are Jeffrey John Bednarski, MD (4 shared papers), Morton J. Cowan, MD (4 shared papers) and Christopher C. Dvorak, MD (4 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card